Asthma: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Terminated

  Probiotics and Insulin Resistance in Obese Asthmatics

  NCT05949255· University of Alabama at Birmingham· Updated 5 Nov 2026

  “Lost coordinator and statistician before no cost extension study could be completed.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma

  NCT07869043· Pfizer· Source

• A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  NCT07219173· Eli Lilly and Company· Source

• A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

  NCT07645248· GlaxoSmithKline· Source

• A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

  NCT07556159· Sanofi· Source

• A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)

  NCT07782996· GlaxoSmithKline· Source

• A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

  NCT07712393· GlaxoSmithKline· Source

• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  NCT05757102· GlaxoSmithKline· Source

• A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· Teva Branded Pharmaceutical Products R&D LLC· Source

• Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab

  NCT07363642· AstraZeneca· Source

• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  NCT06664619· Teva Branded Pharmaceutical Products R&D LLC· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 18
• Organoids 2
• Mendelian Randomization Analysis 78
• Gene Expression Profiling 73
• Sequence Analysis, RNA 7
• Whole Genome Sequencing 1
• Exome Sequencing 2
• Proteomics 26
• Metabolomics 47
• Mass Spectrometry 16
• Flow Cytometry 18
• Immunohistochemistry 12
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 1
• Magnetic Resonance Imaging 12
• Machine Learning 65
• Deep Learning 10
• Cohort Studies 248
• Genome-Wide Association Study 99

• Identification and Validation of Autophagy- and Inflammatory-Related Genes in Childhood Asthma via Integrated Bioinformatics and Clinical Samples.

  J Vis Exp, Nov 2026

• Tezepelumab alters airway epithelial transcriptional responses and epithelial-smooth muscle signalling in uncontrolled asthma.

  Front Immunol, Oct 2026

• Coordinated transcriptional and epigenetic regulation of type 2 CD8+ T cells in asthma.

  Front Immunol, Oct 2026

• House Dust Mite Induces Distinct Cellular and Extracellular Vesicle-Associated miRNA Signatures in BEAS-2B Cells: Targeted Analysis of IL-4 Responses.

  Cells, Sept 2026

• Blood eosinophils as predictors of asthma exacerbations in adults: converging evidence from mendelian randomization, single-cell transcriptomics, and a two-center longitudinal cohort.

  Front Immunol, Sept 2026

• From disease to syndrome pattern: a study on the differentiation of traditional Chinese medicine syndrome patterns in asthma using multi-omics characterization.

  Front Immunol, Sept 2026

• Identification and experimental validation of CCL26 as a core comorbid gene and biomarker for atopic dermatitis and allergic asthma via machine learning and multi-omics analysis.

  Front Immunol, Sept 2026

• Nasal Epithelial Immune Signatures Are Associated With Age-Dependent Asthma Trajectories in Early Life.

  Allergy, Sept 2026

• Elucidating molecular mechanisms of allergic sensitization to olive pollen through transcriptomics.

  Front Immunol, Sept 2026

• Cross-Cohort Transcriptomic Prioritization and Chemical-Provenance Assessment of Asthma Airway-Brushing Genes Overlapping HERB-Annotated Scrophularia ningpoensis Targets.

  Int J Mol Sci, Sept 2026

See which targets of this disease your abstract mentions, and go to the people working on them.